Answers are grounded in this paper and cite their sources.
Review evaluates vitamin D supplementation's effect on immune modulation in Hashimoto's thyroiditis, implying novel treatment protocols.
Background To evaluate vitamin D’s role in thyroid autoimmunity modulation, establish evidence-based supplementation protocols, and address surgical implications in Hashimoto’s thyroiditis (HT) care. Vitamin D deficiency is prevalent in HT patients and correlates with accelerated autoimmune progression. This review synthesizes mechanistic insights and clinical implications of vitamin D repletion in HT management. Objective To evaluate vitamin D’s role in thyroid autoimmunity modulation, establish evidence-based supplementation protocols, and address surgical implications in HT care. Key Findings Pathogenic Mechanism: Vitamin D deficiency (25(OH)D <20 ng/mL) disrupts VDR-mediated Treg/Th17 balance, increasing anti-TPO titers by 40–60% and hypothyroidism progression risk. Therapeutic Window: Supplementation (2000–4000 IU/day) reduces antibodies by 15–30% only in euthyroid TPOAb+ patients with baseline deficiency (<20 ng/mL), but efficacy diminishes in overt hypothyroidism. Surgical Imperative: Preoperative optimization (25(OH)D >30 ng/mL) lowers post-thyroidectomy hypocalcemia risk by 50% in HT patients. Conclusion Vitamin D modulates HT through immune pathway regulation, yet response heterogeneity necessitates: Genotype-guided dosing (VDR-FokI FF carriers require 30% lower doses). Vitamin D supplementation has demonstrated potential to modulate immune responses, alleviate symptoms, and improve quality of life.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: